Stacie has over 20 years of academic, clinical research, and consulting experience, including multiple publications and presentations across various disease states, and extensive expertise in both oncology and diabetes. She has also worked cross-functionally with regulatory, biostatistics, and marketing groups to inform and support PRO measurement strategies in product development.
In this video recorded with other industry experts about patient-reported outcomes, Stacie discusses how a PRO system enables clinicians and researchers to “not only quantify the patient experience but also allows to track the patient symptom experience for individuals and groups of patients in different cancer types, but in different treatment areas over time. We’re also able to monitor and quantify different treatment pathways along the way.”
Utilizing PROs as a measuring stick for patient experience, Centers and patients are making more informed, data-driven decisions.
